1 - 25 of
78
results
for author:"Chenevix-Trench G."
in Literature Citations
| Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Kathleen Cuningham Foundation Consortium for Research into Familial Aspects of Breast Cancer (kConFab) Am. J. Hum. Genet. 85:427-446(2009) · Mapped (8) |
| The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Consortium of Investigators of Modifiers of BRCA1/2 Br. J. Cancer 101:1456-1460(2009) · Mapped (100) |
| Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer Hum. Mol. Genet. 18:4442-4456(2009) · Mapped (65) |
| Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. Rebbeck T.R., Mitra N., Domchek S.M., Wan F., Chuai S., Friebel T.M., Panossian S., Spurdle A., Chenevix-Trench G., Singer C.F. et al. Cancer Res. 69:5801-5810(2009) · Mapped (85) |
| Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium. Johnatty S.E., Beesley J., Chen X., Spurdle A.B., Defazio A., Webb P.M., Goode E.L., Rider D.N., Vierkant R.A., Anderson S. et al. Twin Res Hum Genet 12:269-275(2009) · Mapped (1) |
| Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Breast Cancer Association Consortium Cancer Epidemiol. Biomarkers Prev. 18:1610-1616(2009) · Mapped (30) |
| Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. GENICA Consortium Nat. Genet. 41:585-590(2009) · Mapped (14) |
| Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Ovarian Cancer Association Consortium (OCAC) Hum. Mol. Genet. 18:2297-2304(2009) · Mapped (5) |
| Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Schildkraut J.M., Goode E.L., Clyde M.A., Iversen E.S., Moorman P.G., Berchuck A., Marks J.R., Lissowska J., Brinton L., Peplonska B. et al. Cancer Res. 69:2349-2357(2009) · Mapped (31) |
| Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors. Arnold J.M., Choong D.Y., Thompson E.R., Waddell N., Lindeman G.J., Visvader J.E., Campbell I.G., Chenevix-Trench G. Breast Cancer Res. Treat. 0:0-0(2009) · Mapped (2) |
| Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Pearce C.L., Near A.M., Van Den Berg D.J., Ramus S.J., Gentry-Maharaj A., Menon U., Gayther S.A., Anderson A.R., Edlund C.K., Wu A.H. et al. Br. J. Cancer 100:412-420(2009) · Mapped (48) |
| Association of ESR1 gene tagging SNPs with breast cancer risk. Dunning A.M., Healey C.S., Baynes C., Maia A.T., Scollen S., Vega A., Rodriguez R., Barbosa-Morais N.L., Ponder B.A., Low Y.L. et al. Hum. Mol. Genet. 18:1131-1139(2009) · Mapped (53) |
| No evidence that GATA3 rs570613 SNP modifies breast cancer risk. Breast Cancer Association Consortium and Consortium of Investigators of Modifiers of BRCA1/2 Breast Cancer Res. Treat. 117:371-379(2009) · Mapped (45) |
| Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Ovarian Cancer Association Consortium Cancer Epidemiol. Biomarkers Prev. 17:3567-3572(2008) · Mapped (1,109) |
| Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors. Anglesio M.S., Arnold J.M., George J., Tinker A.V., Tothill R., Waddell N., Simms L., Locandro B., Fereday S., Traficante N. et al. Mol. Cancer Res. 6:1678-1690(2008) · Mapped (8) |
| ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy. Johnatty S.E., Beesley J., Paul J., Fereday S., Spurdle A.B., Webb P.M., Byth K., Marsh S., McLeod H., Harnett P.R. et al. Clin. Cancer Res. 14:5594-5601(2008) · Mapped (8) |
| No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Spurdle A.B., Deans A.J., Duffy D., Goldgar D.E., Chen X., Beesley J., Easton D.F., Antoniou A.C., Peock S., Cook M. et al. Breast Cancer Res. Treat. 115:307-313(2009) · Mapped (51) |
| No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study. Rebbeck T.R., Antoniou A.C., Llopis T.C., Nevanlinna H., Aittomaki K., Simard J., Spurdle A.B., Couch F.J., Pereira L.H., Greene M.H. et al. Breast Cancer Res. Treat. 115:185-192(2009) · Mapped (52) |
| BRCA1 and BRCA2 missense variants of high and low clinical significance influence lymphoblastoid cell line post-irradiation gene expression. Waddell N., Ten Haaf A., Marsh A., Johnson J., Walker L.C., Investigators K., Gongora M., Brown M., Grover P., Girolami M. et al. PLoS Genet. 4:e1000080-e1000080(2008) · Mapped (43) |
| The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case-control and family analysis. Kathleen Cuningham Consortium for Research in Familial Breast Cancer Breast Cancer Res. Treat. 115:145-150(2009) · Mapped (5) |
| Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. Garcia-Closas M., Hall P., Nevanlinna H., Pooley K., Morrison J., Richesson D.A., Bojesen S.E., Nordestgaard B.G., Axelsson C.K., Arias J.I. et al. PLoS Genet. 4:e1000054-e1000054(2008) · Mapped (25) |
| Consortium analysis of 7 candidate SNPs for ovarian cancer. Ovarian Cancer Association Consortium Int. J. Cancer 123:380-388(2008) · Mapped (57) |
| Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators. Spurdle A.B., Lakhani S.R., Healey S., Parry S., Da Silva L.M., Brinkworth R., Hopper J.L., Brown M.A., Babikyan D., Chenevix-Trench G. et al. J. Clin. Oncol. 26:1657-1663(2008) · Mapped (43) |
| Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Kathleen Cuningham Consortium for Research into Familial Breast Cancer Am. J. Hum. Genet. 82:937-948(2008) · Mapped (58) |
| Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. Gene Environment Interaction and Breast Cancer in Germany Group, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer Investigators, Australian Ovarian Cancer Study Management Group J. Natl. Cancer Inst. 100:437-442(2008) · Mapped (9) |
